The present stock price for RxSight Inc (RXST) is $8.31. In the last trading session, the stock made a considerable jump, reaching $11.0 after an opening price of $8.31. The stock briefly fell to $8.0 before ending the session at $7.35.
RxSight Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $58.23 on 08/26/24 and the lowest value was $6.32 on 07/09/25.
52-week price history of RXST Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. RxSight Inc’s current trading price is -85.73% away from its 52-week high, while its distance from the 52-week low is 31.49%. The stock’s price range during the 52-week period has remained between $6.32 and $58.23. In the Healthcare sector, the company’s shares saw a trading volume of around 2.05 million for the day, which was evidently higher than the average daily volume of 1.27 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
RxSight Inc (RXST) has experienced a quarterly decline of -37.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 340.01M and boasts a workforce of 498 employees.
A Closer Look at Analysts’ Ratings for RxSight Inc
As of right now, 0 analyst is rating RxSight Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 8 analysts are recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.74, with a change in price of -16.59. Similarly, RxSight Inc recorded 1,259,273 in trading volume during the last 100 days, posting a change of -66.63%.
Examining RXST’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RXST stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.04.
RXST Stock Stochastic Average
As of today, RxSight Inc’s raw stochastic average for the last 50 days stands at 19.82%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 90.37%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 45.11% and 32.23%, respectively.
RXST Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price loss of -83.62% this year. Over the last six months, there has been a stronger performance of -74.18%. The price of RXST fallen by 11.54% during the last 30 days period. For the last 5-days stocks have improved 10.07%.
